Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymphoseek vs Vital Blue Dye for Lymph Node Mapping
NCT01106040Phase 3Completed
- Sponsor
- Navidea Biopharmaceuticals, Inc.
- Start
- Jun 2010
- Primary completion
- Apr 2011
- Countries
- 1
01
Overview
A Phase 3 trial of technetium tc 99m tilmanocept in melanoma, breast cancer, sponsored by Navidea Biopharmaceuticals, Inc.. Started Jun 2010; status: completed.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
melanomabreast cancer
Beyond the preview
Go deeper on NCT01106040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01106040.